Human PLCB1 ELISA Kit
Product Name:Human PLCB1 ELISA Kit
Packing:96T
Catalog No.:ELA-E1605h
Gene Name:PLCB1
Detect Range:1.56-100 ng/mL
Sensitivity:0.39 ng/mL
Target Protein Name:Human 1-phosphatidylinositol-4, 5-bisphosphate phosphodiesterase beta-1
Alternative Name:1-phosphatidylinositol-4, 5-bisphosphate phosphodiesterase beta-1, PLC-154, Phosphoinositide phospholipase C-beta-1, Phospholipase C-I, PLC-I, Phospholipase C-beta-1, PLC-beta-1,
Sample type:serum, plasma, tissue homogenates, cell culture supernates or other biological fluids.
ELISA type:Sandwich ELISA Kit
Product Description:Human PLCB1 ELISA Kit allows for the in vitro quantitative determination of Human 1-phosphatidylinositol-4, 5-bisphosphate phosphodiesterase beta-1 concentrations in serum, plasma, tissue homogenates, cell culture supernates or other biological fluids.
ELISA Test Principle:
The microtiter plate provided in Human PLCB1 ELISA Kit has been pre-coated with an PLCB1 antibody specific to Human 1-phosphatidylinositol-4, 5-bisphosphate phosphodiesterase beta-1 .Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody preparation specific for Human 1-phosphatidylinositol-4, 5-bisphosphate phosphodiesterase beta-1 and then avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then a TMB substrate solution is added to each well. Only those wells that contain Human 1-phosphatidylinositol-4, 5-bisphosphate phosphodiesterase beta-1, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of a sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450 nm
Technical Principle & Methodology
The quality assurance and experimental performance of this biological reagent are rigorously optimized and standardized according to its specific technical pathway:
Double Antibody Sandwich Method
(双抗体夹心法). This ensures maximum reproducibility across clinical research and scientific workflows.